Home >
Medicine Info >
Magnamycin 250 mg Injection
Loading interface...

Magnamycin 250 mg Injection

Manufactured byPfizer Ltd.
ContainsCefoperazone
Description
Magnamycin 250 mg Injection is an antibiotic used to treat bacterial infections that affect your nose, throat, lungs, urinary tract, skin, bones, joints, etc. It works by preventing the formation of the bacterial cell wall (protective covering), thus killing the infection-causing bacteria. This medication is effective only for the treatment of infections caused by bacteria and not viruses. Magnamycin 250 mg Injection may cause common side effects such as skin rash, nausea/vomiting, diarrhoea, etc. Consult your doctor if these symptoms persist or worsen. Magnamycin 250 mg Injection is administered by a qualified healthcare professional in a clinic or hospital setting. Do not self-administer this medicine. The dose and duration of treatment will depend on your condition. Follow all the instructions given by your doctor. Magnamycin 250 mg Injection is not recommended for use if you are allergic to it. Inform your doctor if you have any kidney or liver problems before starting treatment with this medicine. If you are pregnant or are breastfeeding, consult your doctor before receiving this medication.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Substitutes

List of substitutes for Magnamycin 250 mg Injection

Myticef 250 mg Injection
Panacea Biotec Ltd.

Side effects

Major & minor side effects for Magnamycin 250 mg Injection

  • Diarrhoea
  • Nausea and Vomiting
  • Skin rash
  • Decrease in blood cell count
  • Decreased haemoglobin level
  • Headache
  • Pain at injection site
  • Fever with chills
  • Increased liver enzyme levels

Uses of Magnamycin 250 mg Injection

What is it prescribed for?

  • Upper Respiratory Tract Infection
  • Lower Respiratory Tract Infection
  • Urinary Tract Infection
  • Intraabdominal Infection
  • Bacterial Septicaemia
  • Skin and Soft tissue infections
  • Bone and Joint infections
  • Genital Infections
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The time required by Magnamycin 250 mg Injection to show its effect is not clinically known.
  • How long do the effects of this medicine last?
    Magnamycin 250 mg Injection remains active in your body for an approximate duration of 12 hours after administration.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with Magnamycin 250 mg Injection due to the increased risk of side effects such as flushing (reddening of your skin, usually of the face), nausea, vomiting, and fast heartbeat.
  • Is this a habit forming medicine?
    No habit-forming tendencies have been reported with Magnamycin 250 mg Injection.
  • Can this medicine be taken during pregnancy?
    Magnamycin 250 mg Injection may be used during pregnancy upon your doctor's recommendation as animal studies indicate no harm to the foetus. However, human data is not available. Hence, consult your doctor to understand the potential benefits and risks before receiving the medicine.
  • Can this medicine be taken while breast-feeding?
    Magnamycin 250 mg Injection may pass into the breastmilk in low amounts, hence it should be used with caution while breastfeeding. Consult your doctor if you are breastfeeding to understand the potential benefits and risks.

Allergy

Magnamycin 250 mg Injection is not recommended for use if you are allergic to it. Seek immediate medical attention if you notice any symptoms such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.
Warnings for special population

Pregnancy

Magnamycin 250 mg Injection may be used during pregnancy upon your doctor's recommendation as animal studies indicate no harm to the foetus. However, human data is not available. Hence, consult your doctor to understand the potential benefits and risks before receiving the medicine.

Breast-feeding

Magnamycin 250 mg Injection may pass into the breastmilk in low amounts, hence it should be used with caution while breastfeeding. Consult your doctor if you are breastfeeding to understand the potential benefits and risks.
General warnings

Antibiotic resistance

Antibiotic resistance occurs when bacteria develop the ability to defeat the medicine that was intended to kill them. This can be avoided by following the dose and duration of treatment as prescribed by your doctor. Finish the entire course of treatment with Magnamycin 250 mg Injection even if your symptoms get better after a few doses.

Diarrhoea

Magnamycin 250 mg Injection can cause diarrhoea as it may also kill the helpful bacteria in your stomach or intestine. Get emergency medical help if you experience severe watery or bloody diarrhoea. Consult your pharmacist/doctor before taking anti-diarrhoeal medication.

For parenteral use only

Magnamycin 250 mg Injection is meant to be administered either by intravenous route (injected through the vein) or by intramuscular route (injected into the muscles) only.

Missed Dose

As Magnamycin 250 mg Injection is administered in the hospital setting by a qualified healthcare professional, the likelihood of a missed dose is very low.

Overdose

As Magnamycin 250 mg Injection is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very low. Moreover, emergency medical treatment will be initiated by your doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with Magnamycin 250 mg Injection due to the increased risk of side effects such as flushing (reddening of your skin, usually of the face), nausea, vomiting, and fast heartbeat.
Interaction with Medicine

Probenecid

Ethinyl Estradiol

Warfarin

Disease interactions

Kidney/Liver Disease

Magnamycin 250 mg Injection should be used with caution if you have pre-existing kidney/liver problems due to the increased risk of side effects. Your doctor may suggest tests to monitor your kidney/liver function and recommend dose adjustments based on your clinical condition.
Food interactions
Information not available.
Lab interactions

Coombs test

Coombs tests is done to find certain antibodies (proteins made by the immune system) that attack red blood cells. Use of Magnamycin 250 mg Injection may give a false result for the Coombs test.

Urine Sugar Test (Benedict's of Fehling's reagent)

Benedict's or Fehling's Test is done to determine sugar levels in the urine. Magnamycin 250 mg Injection may give a false-positive result for the determination of sugar in your urine with Benedict's or Fehling's reagent. Hence, inform your doctor or lab technician that you are receiving Magnamycin 250 mg Injection before the lab test.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Magnamycin 250 mg Injection is administered in the clinic/hospital setting under the supervision of a qualified healthcare professional. If you experience any reactions at the site of injection (redness/pain/swelling) that become bothersome, inform your doctor immediately. Magnamycin 250 mg Injection may cause diarrhoea. Consult your doctor if you experience a severe worsening of your condition. Magnamycin 250 mg Injection may affect your blood cell count, haemoglobin levels, and liver enzyme levels. Your doctor may suggest tests to monitor your blood cell counts and liver enzyme levels during treatment with this medicine.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Magnamycin 250 mg Injection works by preventing the formation of the bacterial cell wall, the outer covering required for the bacterial cells to stay alive. Thus it kills the infection-causing bacteria.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Third generation cephalosporins, Antibiotics

Schedule

Schedule H1

Pubchem.ncbi.nlm.nih.gov. 2021. Cefoperazone. [online] Available at: < [Accessed 12 November 2021].

https://pubchem.ncbi.nlm.nih.gov/compound/Cefoperazone>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 20 November 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/050551s043lbl.pdf>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 1 Mar 2022

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.